Kirk Coleman's Insider Trades & SAST Disclosures
Kirk Coleman's most recent trade in Q2 Holdings Inc was a trade of 30,443 Common Stock done . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kirk Coleman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 30,443 | 303,404 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 15,222 | 318,626 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 15,221 | 333,847 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 80.89 per share. | 04 Mar 2025 | 19,467 | 272,961 (0%) | 0% | 80.9 | 1,574,686 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 88.75 per share. | 21 Feb 2025 | 45,215 | 292,428 (0%) | 0% | 88.7 | 4,012,831 | Common Stock |
| Q2 Holdings Inc | Kirk Coleman L. | President | Sale of securities on an exchange or to another person at price $ 106.42 per share. | 10 Dec 2024 | 10,428 | 337,643 (0%) | 0% | 106.4 | 1,109,748 | Common Stock |
| Q2 Holdings Inc | Kirk Coleman L. | President | Sale of securities on an exchange or to another person at price $ 106.00 per share. | 10 Dec 2024 | 8,559 | 340,903 (0%) | 0% | 106 | 907,254 | Common Stock |
| Q2 Holdings Inc | Coleman L. Kirk | President | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Dec 2024 | 7,168 | 348,071 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 10,184 | 45,859 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 10,184 | 10,184 | - | - | Stock Options (Right to Buy) | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 61.26 per share. | 10 Jun 2024 | 3,537 | 352,177 (0%) | 0% | 61.3 | 216,677 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 60.31 per share. | 10 Jun 2024 | 2,715 | 349,462 (0%) | 0% | 60.3 | 163,742 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 10,600 | 10,600 | - | - | Restricted stock units | |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 5,300 | 5,300 | - | - | Restricted stock units | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 53,568 | 302,146 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 26,784 | 328,930 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 26,784 | 355,714 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 46.50 per share. | 04 Mar 2024 | 4,437 | 248,578 (0%) | 0% | 46.5 | 206,321 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 46.01 per share. | 04 Mar 2024 | 2,904 | 253,015 (0%) | 0% | 46.0 | 133,613 | Common Stock |
| Q2 Holdings Inc | Coleman L. Kirk | President | Sale of securities on an exchange or to another person at price $ 38.31 per share. | 13 Dec 2023 | 7,007 | 258,601 (0%) | 0% | 38.3 | 268,438 | Common Stock |
| Q2 Holdings Inc | Kirk Coleman L. | President | Sale of securities on an exchange or to another person at price $ 38.31 per share. | 13 Dec 2023 | 1,498 | 257,103 (0%) | 0% | 38.3 | 57,388 | Common Stock |
| Q2 Holdings Inc | L. Coleman Kirk | President | Sale of securities on an exchange or to another person at price $ 41.18 per share. | 13 Dec 2023 | 1,184 | 255,919 (0%) | 0% | 41.2 | 48,757 | Common Stock |
| Q2 Holdings Inc | Coleman Kirk L. | President | Sale of securities on an exchange or to another person at price $ 38.31 per share. | 13 Dec 2023 | 1,083 | 265,608 (0%) | 0% | 38.3 | 41,490 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 15 Aug 2023 | 20,000 | 35,675 (0%) | 0% | 0.3 | 5,000 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 35,868 | 236,119 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 17,934 | 271,987 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 17,934 | 254,053 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2023 | 100,000 | 100,000 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 10 Mar 2023 | 12,000 | 15,675 (0%) | 0% | 0.8 | 9,457 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 47,111 | 153,140 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 23,556 | 176,696 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 23,555 | 200,251 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk Coleman L. | President | Sale of securities on an exchange or to another person at price $ 37.78 per share. | 11 Feb 2023 | 5,296 | 266,691 (0%) | 0% | 37.8 | 200,083 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 27.03 per share. | 12 Dec 2022 | 2,874 | 106,029 (0%) | 0% | 27.0 | 77,684 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2022 | 74,405 | 108,903 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.40 per share. | 16 May 2022 | 1,250 | 3,250 (0%) | 0% | 4.4 | 5,500 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.83 per share. | 16 May 2022 | 425 | 3,675 (0%) | 0% | 4.8 | 2,053 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Purchase of securities on an exchange or from another person at price $ 7.30 per share. | 16 Sep 2021 | 1,000 | 2,000 (0%) | 0% | 7.3 | 7,300 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 15 Mar 2021 | 5,000 | 6,000 (0%) | 0% | 2.5 | 12,500 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Sale of securities on an exchange or to another person at price $ 17.05 per share. | 15 Mar 2021 | 5,000 | 1,000 (0%) | 0% | 17.1 | 85,250 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 5,000 | 277,883 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 5,000 | 282,883 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Sale of securities on an exchange or to another person at price $ 16.82 per share. | 16 Feb 2021 | 5,000 | 1,000 (0%) | 0% | 16.8 | 84,100 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 16 Feb 2021 | 5,000 | 6,000 (0%) | 0% | 2.5 | 12,500 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 5,000 | 287,883 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 15 Jan 2021 | 5,000 | 1,000 (0%) | 0% | 17.5 | 87,500 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 15 Jan 2021 | 5,000 | 6,000 (0%) | 0% | 2.5 | 12,500 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Sale of securities on an exchange or to another person at price $ 15.24 per share. | 23 Dec 2020 | 10,000 | 1,000 (0%) | 0% | 15.2 | 152,400 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2020 | 10,000 | 292,883 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 23 Dec 2020 | 10,000 | 11,000 (0%) | 0% | 2.5 | 25,000 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary, and Treasurer | Sale of securities on an exchange or to another person at price $ 15.12 per share. | 10 Nov 2020 | 15,000 | 1,000 (0%) | 0% | 15.1 | 226,755 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary, and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 10 Nov 2020 | 15,000 | 16,000 (0%) | 0% | 2.5 | 37,500 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary, and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2020 | 15,000 | 302,883 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary, and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2020 | 40,000 | 317,883 | - | - | Stock Options (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges